Aug 8, 2023 04:05PM
Feb 28, 2023 04:06PM
Jan 9, 2023 05:11AM
Jan 6, 2023 06:00PM
Nov 8, 2022 04:05PM
Oct 20, 2022 08:02AM
Oct 20, 2022 08:00AM Revance Submits Supplemental Biologics License Application (sBLA) for DAXXIFY™ (DaxibotulinumtoxinA-lanm) for Injection for the Treatment of Cervical Dystonia
Aug 9, 2022 04:05PM
May 10, 2022 04:05PM
Apr 21, 2022 04:06PM
Apr 21, 2022 04:05PM
Mar 22, 2022 06:28AM
Mar 8, 2022 10:08AM
Jan 10, 2022 06:40AM Revance Therapeutics' (RVNC) Remains on Track to Submit Daxi BLA in 1H22 and get New PDUFA in 2H22 - Needham
Oct 13, 2021 05:23AM
Nov 25, 2020 08:30AM
Nov 9, 2020 05:00PM
Nov 9, 2020 04:05PM
Nov 9, 2020 04:05PM
Oct 14, 2020 08:01AM
Oct 14, 2020 08:00AM Revance Reports Positive Results from ASPEN-1 Phase 3 Trial of DaxibotulinumtoxinA for Injection in Cervical Dystonia
Oct 6, 2020 08:00AM
Sep 8, 2020 04:05PM
Sep 2, 2020 08:00AM
Aug 25, 2020 08:00AM
Aug 11, 2020 08:31AM
Aug 11, 2020 08:30AM
Aug 6, 2020 04:05PM Revance Reports Second Quarter 2020 Financial Results, Provides Corporate Update
Jun 30, 2020 08:01AM
Jun 30, 2020 08:00AM
May 7, 2020 04:05PM
Mar 26, 2020 04:21PM
Mar 26, 2020 04:05PM
Feb 26, 2020 08:59AM
Feb 24, 2020 04:05PM Revance Reports Fourth Quarter and Full Year 2019 Financial Results, Provides Corporate Update
Feb 6, 2020 08:15AM
Feb 6, 2020 08:00AM
Nov 25, 2019 08:00AM
Nov 25, 2019 08:00AM

15,418 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All